![]() |
|
|
Vol. 291, Issue 2, 634-641, November 1999
Department of Applied Pharmacology, Kyoto Pharmaceutical University, Misasagi, Yamashina, Kyoto, Japan
| |
Abstract |
|---|
|
|
|---|
We investigated the role of endogenous interleukin (IL)-1 in the mRNA
expression of cyclooxygenase (COX)-1, COX-2, inducible nitric oxide
synthase (iNOS), cytokine-induced neutrophil chemoattractant (CINC)-1,
epidermal growth factor (EGF), basic fibroblast growth factor (bFGF),
hepatocyte growth factor (HGF), and transforming growth factor
(TGF)-
1 in acetic acid-induced gastric ulcers in rats. IL-1
mRNA
was not detected in the normal or intact mucosa of ulcerated stomachs,
but its expression was induced in the ulcerated tissue. IL-1
immunoreactivity was observed in macrophages/monocytes and fibroblasts
in the ulcer base. COX-2, iNOS, and CINC-1 mRNAs were expressed by
ulceration. EGF, bFGF, HGF, and TGF-
1 mRNA expression was detected
in the normal mucosa, and their levels were significantly elevated by
ulceration. In contrast, COX-1 mRNA level did not differ between the
normal and ulcerated tissues. In a culture of isolated ulcer bases,
block of IL-1 with IL-1 receptor antagonist (IL-1RA) dose-dependently
and significantly reduced the mRNA levels of COX-2, iNOS, CINC-1, HGF,
and bFGF. In contrast, COX-1, EGF, and TGF-
1 mRNA expression was not
affected by IL-1RA. IL-1RA dose-dependently reduced prostaglandin
E2 production, total and iNOS activities, neutrophil
chemotactic activity, and growth-promoting activity toward gastric
epithelial cells in the ulcer base. Finally, the administration of
IL-1RA caused a significant impairment of ulcer healing. These results
indicate that IL-1, expressed in macrophages/monocytes and fibroblasts
in the ulcer base, might up-regulate the mRNA expression of COX-2,
iNOS, CINC-1, HGF, and bFGF, thereby contributing to gastric ulcer
healing in rats.
| |
Introduction |
|---|
|
|
|---|
Proinflammatory
cytokine interleukin (IL)-1 exerts numerous biological effects on
multiple cell types and plays a central role in the regulation of
inflammatory reactions (Dinarello, 1996
). The basis for these IL-1
actions is considered to be the effect on the gene expression of
cytokines, growth factors and their receptors, cyclooxygenase (COX)-2,
and inducible nitric oxide synthase (iNOS). Kinoshita et al. (1995)
and
we (Takahashi et al., 1998
) reported that IL-1
and IL-1
mRNA
expression is induced by gastric ulceration in rats. Other studies also
revealed that IL-1 mRNA and protein are highly expressed in the gastric
mucosa of Helicobacter pylori-positive patients with
gastritis and ulcers (Noach et al., 1994
; Yamaoka et al., 1996
). In
addition, in ulcerated gastric tissue, the production of cytokines
other than IL-1, growth factors, and autacoids is also elevated for
mucosal regeneration. Consequently, we postulated that IL-1 may
regulate mRNA expression of these factors in ulcerated tissue.
Therefore, the present study was designed to investigate the effect of
locally produced IL-1 on the expression of COX-1, COX-2, iNOS,
cytokine-induced neutrophil chemoattractant-1 (CINC-1), epidermal
growth factor (EGF), basic fibroblast growth factor (bFGF), hepatocyte
growth factor (HGF), and transforming growth factor (TGF)-
1 in
gastric ulcers in rats. Because IL-1 has both systemic and local
effects (Dinarello, 1996
), we examined the effect of IL-1 receptor
antagonist (IL-1RA) in a culture of isolated ulcer bases. In addition,
the effect of IL-1RA on ulcer healing was examined. Based on the
obtained data, we discuss the pharmacological relevancies of IL-1 in
gastric ulcer healing.
| |
Materials and Methods |
|---|
|
|
|---|
Production of Gastric Ulcers.
Male Donryu rats (Nihon SLC,
Hamamatsu, Japan), weighing 250 to 300 g, were fasted for 5 h
before ulcer induction. Under ether anesthesia, gastric ulcers were
induced by submucosal injection of 20% acetic acid (0.04 ml) into the
border between the antrum and fundus on the anterior wall of the
stomach (Takagi et al., 1969
). After closure of the abdomen, the rats
were maintained in the usual manner. Because deep and well-defined
ulcers were observed 5 days after the acid injection, we defined the
fifth day as the day of ulceration (day 0). On the indicated days, rats were sacrificed and their stomachs were excised. Subsequently, the
stomachs were incised along the greater curvature, and the ulcerated
area (mm2) was blindly determined under a dissecting
microscope (X10; Olympus, Tokyo, Japan).
Northern Blot Analysis of mRNA Expression.
Rat IL-1
(Herskowitz et al., 1995
), COX-1 (Feng et al., 1993
), COX-2 (Feng et
al., 1993
), iNOS (Lyons et al., 1992
), EGF (Fan et al., 1995
), bFGF
(El-Husseini et al., 1992
), HGF (Kinoshita et al., 1995
), and TGF-
1
(Siegling et al., 1994
) cDNA probes were prepared by means of reverse
transcription-polymerase chain reaction. In addition, the primers for
rat CINC-1 were 5'-AGCACCATGGTCTCAGCCACC-3' and
5'-TGCCGCCCTTCTTCCCGCTC-3', and total RNA for the amplification of
CINC-1 cDNA was isolated from the spleen of a
lipopolysaccharide-infused rat (5 mg/kg/h, 2 h). The products
corresponding to IL-1
[520 base pairs (bp)], COX-1 (887 bp), COX-2
(702 bp), iNOS (651 bp), CINC-1 (591 bp), EGF (566 bp), bFGF (354 bp),
HGF (580 bp), and TGF-
1 (396 bp) were purified from polyacrylamide
gels and used as probes after their sequences had been confirmed to be
completely identical with known ones (with reference to the GenBank and
EMBL databases). Human glyceraldehyde-3-phosphate dehydrogenase (GAPDH) cDNA probe was purchased from Clontech (Palo Alto, CA). The cDNA probes
were 32P-labeled by the random primer method (Ready-To-Go;
Pharmacia Biotec, Uppsala, Sweden).
Immunohistochemical Analysis of IL-1
Protein.
Gastric
specimens were taken from both intact (posterior side) and ulcerated
(anterior side) tissues of stomachs with ulcers and from normal ones
without ulcers. After they had been fixed with 4% paraformaldehyde in
PBS, frozen sections (12 µm thick) were prepared. The sections were
incubated with anti-rat IL-1
antibody (Endogen, Cambridge, MA) after
deactivation of endogenous peroxidase with 0.3%
H2O2 and blockage of nonspecific binding sites.
IL-1
was visualized by the avidin-biotin-peroxidase complex method
using a Vectastain ABC-peroxidase kit (Vector Laboratories, Burlingame,
CA) and 3',3'-diaminobenzidine tetrahydrochloride (Dojindo
Laboratories, Kumamoto, Japan). The sections were successively stained
with hematoxylin. Macrophage/monocytes were identified by staining due
to macrophage-specific esterase activity (Sigma Chemical Co., St.
Louis, MO).
Culture of Isolated Gastric Tissues.
To evaluate local
regulation of the expression of cytokines and growth factors, we
recently established a method for the culture of gastric tissues
(Takahashi et al., 1998
). In brief, on day 3, ulcer bases were excised
and divided into six fragments. The fragments were washed five times
with Dulbecco's modified Eagle's medium (DMEM; GIBCO BRL)
supplemented with 10 mM HEPES-NaOH (pH 7.4), 0.5% fetal bovine serum
(GIBCO BRL), 200 U/ml penicillin, 200 U/ml streptomycin, and 0.5 µg/ml amphotericin B. They were then placed onto 48-well culture
plates and incubated in 1.0 ml of the above medium in the presence of
the indicated concentrations of IL-1RA (Peprotech, Rocky Hill, NJ) at
37°C under 5% CO2 in air. Normal gastric tissue was
cultured in the same manner. Thirty-six hours later,
poly(A)+ RNAs were isolated from the fragments and
subjected to Northern blot analysis. Prostaglandin E2
(PGE2) production, NOS activity, neutrophil chemotactic
activity, and growth-promoting activity were also determined as
described below. After a 36-h incubation with IL-1RA, the DNA and RNA
contents were nearly the same as those before culture. Histologically,
granulation tissues in the ulcer bases remained unchanged, and
fibroblasts and immune cells were observed even after the incubation.
Determination of PGE2 Production. After gastric tissues had been cultured, they were washed three times with the medium. They were further incubated in 0.5 ml of the medium at 37°C for 1 h. The amount of PGE2 in the medium was determined by enzyme immunoassay (PGE2 EIA kit; Cayman Chemicals, Ann Arbor, MI). When ulcer bases without treatment with IL-1RA were incubated with 10 µM NS-398 (COX-2-selective inhibitor; Taisho Pharmaceutical Co., Tokyo, Japan) or 5 µg/ml IL-1RA, PGE2 production was also determined. PGE2 production was expressed as pg PGE2/mg tissue/h.
Determination of NOS Activity.
NOS activity was measured as
the conversion of L-[14C]arginine to
[14C]citrulline, as described by Lamarque et al. (1998)
.
After gastric tissues had been cultured, they were washed with 10 mM
HEPES-NaOH buffer (pH 7.4) containing 1 mM dithiothreitol, 10 µg/ml
soybean trypsin inhibitor, 5 µg/ml aprotinin, and 10 µg/ml
leupeptin. The tissues were homogenized in 0.5 ml of the same buffer
with a Potter-Elvehjem homogenizer (Iuchi, Osaka, Japan), followed by
centrifugation at 10,000g for 20 min. The resulting
supernatants were incubated in 0.2 ml of 50 mM phosphate buffer (pH
7.4) containing 50 mM L-valine, 1 mM MgCl2, 0.2 mM CaCl2, 1 mM L-citrulline, 0.3 mM NADPH, 3 µM FAD, 3 µM FMN, 3 µM BH4, and 15 nM
L-[14C]arginine (Amersham, Buckinghamshire,
UK) at 37°C for 20 min. The incubation was terminated by the addition
of 1 ml of Dowex AG 50W-8 (1:1 suspension in water; Sigma Chemical
Co.). The resin was allowed to settle for 30 min, and then the
radioactivity in the supernatants was measured. In addition, when 1 mM
aminoguanidine (iNOS-selective inhibitor; Sigma Chemical Co.) or 5 µg/ml IL-1RA was added to the supernatant derived from ulcer bases
without treatment with IL-1RA, NOS activity was also determined.
Product formation, which was inhibited by 0.2 mM
NG-nitro-L-arginine methyl ester
(Sigma Chemical Co.), was taken as total NOS activity. iNOS activity
was taken as that which was inhibited by
NG-nitro-L-arginine methyl ester
but not by 1 mM EGTA. Constitutive NOS activity was calculated as the
difference between the total NOS and iNOS activities. NOS activity was
expressed as pmol [14C]citrulline/mg protein/min. Protein
concentrations were determined with a protein assay kit (Bio-Rad,
Hercules, CA).
Determination of Neutrophil Chemotactic Activity.
Gastric
extracts were prepared according to the method we described previously
(Fujita et al., 1998
). After gastric tissues had been cultured, they
were washed with 10 mM phosphate buffer (pH 7.2) containing 1 mM
ethylenediaminetetraacetic acid, 200 mM NaCl, and 0.1 mM
phenylmethylsulfonyl fluoride. The tissues were homogenized with a
Potter-Elvehjem homogenizer in the same buffer with 1 ml to 100 mg
tissue. The homogenates were centrifuged at 20,000g for
1 h, and the supernatants were recovered as gastric extracts.
(Otsuka Pharmaceutical Co.,
Tokushima, Japan), or the above buffer alone (as a control for the
chemotactic assay) was added to the lower compartment of the
chemotactic chamber. Neutrophils (1 × 106
cells) were placed in the upper compartment. The chamber was stood for
1 h at 37°C to allow neutrophil migration. Thereafter, the
filter was removed, and the cells were stained with Diff Quick. The
numbers of neutrophils that had migrated to the lower face of the
filter were determined in five randomly chosen fields under a light
microscope (×400).
Determination of Gastric Epithelial Cell Growth-Promoting
Activity.
Epithelial cell line RGM1, which was recently
established from the gastric mucosa of normal rats (Kinoshita et al.,
1995
), was maintained in DMEM supplemented with 10% fetal bovine
serum, 100 U/ml penicillin, 100 U/ml streptomycin, and 0.25 µg/ml
amphotericin B. Cells (3 × 104 cells/0.2 ml of
medium) were inoculated onto 48-well plates, grown to semiconfluence
for 48 h, and then starved for 48 h in DMEM supplemented with
1 mg/ml bovine serum albumen (BSA) at 37°C under 5% CO2
in air.
, or 20 µl of the
extracts prepared above at 37°C for 24 h. After the cells had
been washed twice with 0.2 ml of ice-cold 10% trichloroacetic acid,
they were solubilized in 0.2 ml of 0.3 M NaOH. Then, the radioactivity
in the lysate was measured with a liquid scintillation counter
(Beckman, Fullerton, CA).
Effect of IL-1RA on Ulcer Healing. On day 0, under ether anesthesia, the abdomen of the rats with ulcers was opened, and then the stomach was exposed. IL-1RA or BSA (control) at 10 µg/25 µl was directly injected to ulcerated area. After closure of the abdomen, the animals were maintained in the usual manner. Thereafter, IL-1RA or BSA at 10 µg/0.5 ml was intravenously administered at 2-day intervals for 10 days. On day 10, the ulcerated area was determined as described above.
Statistical Analysis. The data are presented as mean ± S.E. (n = 6- 8). Statistical differences in the dose-response studies were evaluated by Dunnett's multiple comparison test. Student's t test was used for the comparison between two groups. P value of < 0.05 was regarded as significant.
| |
Results |
|---|
|
|
|---|
IL-1
Expression in Gastric Ulcers.
On day 0, there were
round and deep ulcers in all animals, with the ulcerated area being
45.3 ± 5.8 mm2. Thereafter, the area decreased with
time (Fig. 1). On day 3, IL-1
mRNA was
detected as a single band for the ulcerated tissue. However, IL-1
mRNA was not expressed in the normal stomach or an intact section of
gastric tissue with ulcers. High expression of IL-1
mRNA was
observed on day 3, with the level decreasing thereafter. The level was
well associated with ulcer healing.
|
protein
by immunohistochemical staining (Fig. 2).
In the gastric mucosa of the normal stomach, immunoreactivity for
IL-1
protein was not detected. Similarly, there were no appreciable
signals with anti-IL-1
antibody in the gastric glands around ulcers. In contrast, in the ulcer base, apparent IL-1
immunoreactivity was
found in the upper portion. The immunoreactive IL-1
protein was
abundant in mononuclear cells, which were positive as to the staining
due to macrophage-specific esterase activity. In addition, IL-1
immunoreactivity was observed in fibroblasts (spindle-shaped cells).
The number of IL-1
-expressing cells decreased with ulcer healing.
When the antibody preincubated with IL-1
was applied to sections, no
immunoreactive signals were observed.
|
mRNA Expression of Healing-Related Factors in Gastric Ulcers.
We examined the mRNA expression of COX-1, COX-2, iNOS, CINC, EGF, bFGF,
HGF, and TGF-
1 in gastric tissues (Fig.
3). COX-1 mRNA was detected in the normal
mucosa and similarly expressed in the ulcerated tissue. In contrast,
COX-2, iNOS, and CINC-1 mRNAs were not found in the normal mucosa, but
their expression was induced by ulceration. Their levels were higher in
the early phase (day 3) than in the late phase of ulcer healing (day
10; i.e., the expression decreased with ulcer healing). Furthermore, mRNA expression of EGF, bFGF, HGF, and TGF-
1 was also promoted by
ulceration. The levels of these growth factor mRNAs were significantly higher in the ulcerated tissue than in the normal mucosa. EGF, bFGF,
and TGF-
1 mRNA levels remained unchanged during ulcer healing, whereas HGF mRNA expression decreased with the healing.
|
Role of Endogenous IL-1 in COX-2 mRNA Expression in Gastric
Ulcers.
To clarify the role of endogenous IL-1 expressed in
ulcerated gastric tissue, we examined the effect of IL-1RA on a culture of isolated ulcer bases. Figure 4 shows
the effect of IL-1RA on COX mRNA expression and PGE2
production in the ulcer base. Treatment with IL-1RA caused a
dose-dependent and significant decrease in COX-2 mRNA expression.
However, IL-1RA failed to inhibit COX-1 mRNA expression.
PGE2 production in the normal mucosa was low (105.2 ± 15.9 pg/mg/h), whereas the production was markedly promoted by
ulceration. The increased PGE2 production in the ulcer base was associated with the level of COX-2 mRNA. Similar to COX-2 mRNA
expression, the increased production was also significantly reduced by
IL-1RA in a dose-dependent manner. The inhibition by 5 µg/ml IL-1RA
of COX-2 mRNA expression and PGE2 production was 53.7 and
46.2%, respectively, compared with the control. In addition, 10 µM
NS-398 also inhibited PGE2 production by about 65%, but 5 µg/ml IL-1RA had no effect on the production when these agents were
added to the control tissue in the PGE2 production assay.
|
Role of Endogenous IL-1 in iNOS mRNA Expression in Gastric
Ulcers.
We examined the effect of IL-1RA on iNOS mRNA expression
and NOS activity in the ulcer base (Fig.
5). IL-1RA dose-dependently and
significantly reduced iNOS mRNA expression. In the ulcer base, total
NOS activity markedly increased in response to iNOS expression, compared with that in the normal mucosa (11.4 ± 3.2 pmol/mg/min). iNOS activity in the normal mucosa was negligible (2.3 ± 1.8 pmol/mg/min), whereas iNOS activity comprised most of the total NOS
activity in the ulcer base. IL-1RA significantly decreased the total
and inducible NOS activities in a dose-dependent manner. The inhibition by 5 µg/ml IL-1RA of iNOS mRNA expression and the total and inducible NOS activities were 53.3, 66.8, and 52.6%, respectively, compared with
the control. In addition, 1 mM aminoguanidine also reduced the total
and inducible NOS activities to nearly the same extents, with the
inhibition being about 60 and 70%, respectively. However, 5 µg/ml
IL-1RA had no effect on the total and inducible NOS activities when
IL-1RA was added to the control tissue in the NOS activity assay.
|
Role of Endogenous IL-1 in CINC-1 mRNA Expression in Gastric
Ulcers.
Similarly, we examined the effect of IL-1RA on CINC-1 mRNA
expression and neutrophil chemotactic activity in the ulcer base (Fig.
6A). Ulceration-induced CINC mRNA
expression was dose-dependently reduced by IL-1RA, with the inhibition
by 5 µg/ml IL-1RA being significant (i.e., 32.9%). Neutrophil
migration was not promoted by the extract prepared from the normal
mucosa but significantly stimulated by the extract prepared from the
ulcer base to 290.6% compared with the vehicle (Fig. 6B). Treatment
with IL-1RA dose-dependently inhibited the stimulated neutrophil
chemotaxis, with the effect of 5 µg/ml IL-1RA being significant
(70.2% inhibition). When neutrophils were incubated with 100 ng/ml
CINC-1, the migration was significantly stimulated to 356.8%. However,
neither 100 ng/ml IL-1RA nor 5 µg/ml IL-1RA affected neutrophil
migration.
|
Role of Endogenous IL-1 in mRNA Expression of Growth Factors in
Gastric Ulcers.
The effect of IL-1RA on the mRNA expression of
EGF, bFGF, HGF, and TGF-
1 is shown in Fig.
7A. The increased level of HGF mRNA was
dose-dependently and significantly reduced by treatment with IL-1RA.
The inhibition by 10 µg/ml IL-1RA was 59.2% for HGF mRNA expression.
IL-1RA also dose-relatedly decreased bFGF mRNA expression, and a
significant inhibition by 10 µg/ml IL-1RA was observed (35.6%). In
the cases of EGF and TGF-
1 mRNA expression, IL-1RA had no effect.
|
,
and 10 µg/ml IL-1RA had no effect on RGM1 growth.
Role of Endogenous IL-1 in Gastric Ulcer Healing.
Finally, we
investigated the role of endogenous IL-1 in gastric ulcer healing in
rats. The effect of exogenously administered IL-1RA on ulcer healing
was examined. As shown in Fig. 8, IL-1RA significantly impaired the healing of acetic acid-induced ulcers in
rats, compared with the control. The ulcerated areas in the IL-1RA-treated and control groups were 19.4 ± 2.9 and 8.3 ± 1.8 mm2, respectively.
|
| |
Discussion |
|---|
|
|
|---|
We reconfirmed that in response to gastric ulceration, IL-1
mRNA is expressed only in the ulcerated tissue, as described previously
(Takahashi et al., 1998
). This is well consistent with the finding that
IL-1
-expressing cells are localized only in the ulcer base.
Considering their existence in granulation tissue, the cells were
morphologically identified as macrophages/monocytes and fibroblasts.
Most IL-1
-expressing cells were also positive as to staining due to
macrophage-specific esterase activity, indicating that IL-1
is
produced mainly by macrophages/monocytes. Macrophages/monocytes are
well known to be dominant IL-1-producing cells (Dinarello, 1996
). In
addition, IL-1
mRNA level decreased with ulcer healing; it is
suggested that the reduction in infiltration and activation of
macrophages/monocytes and fibroblasts associated with ulcer healing
results in the decrease in IL-1
expression.
As reported by several researchers, the expression of COX-2 (Mizuno et
al., 1997
; Schmassmann et al., 1998
; Shigeta et al., 1998
; Takahashi et
al., 1998
), EGF (Wright et al., 1990
; Konturek et al., 1991
), bFGF
(Folkman et al., 1991
; Satoh et al., 1997
), HGF (Kinoshita et al.,
1995
; Schmassmann et al., 1997
), and TGF-
1 (Tominaga et al., 1997
;
Takahashi et al., 1998
) is induced or promoted by gastric and duodenal
ulceration. In addition, to our knowledge, we describe for the first
time that iNOS and CINC mRNAs are also expressed only in ulcerated
tissue. The mRNA expression of COX-2, iNOS, CINC-1, HGF, and bFGF was
inhibited on the block of IL-1 receptor with IL-1RA. These results
suggest that during the healing of gastric ulcers, IL-1 may serve as
one of the inducers of the mRNA expression of several factors. In
addition, it is suggested that IL-1 type 1 receptor is involved
in the induction of COX-2, iNOS, CINC-1, HGF, and bFGF mRNA expression,
because IL-1RA binds more preferably to the type 1 receptor than the
type 2 receptor (Sims et al., 1993
). The significance of the
IL-1-induced expression of COX-2, iNOS, CINC-1, HGF, and bFGF is
discussed below.
First, our results indicate that IL-1 might induce COX-2 mRNA
expression, resulting in increased PGE2
production in gastric ulcers. Many studies revealed that COX-2 mRNA
expression is induced by IL-1 in several cell types (Dinarello, 1996
;
Herschman, 1996
). The increased production of
PGE2, derived from COX-2, is required for ulcer
healing, as described previously (Mizuno et al., 1997
; Schmassmann et
al., 1998
; Shigeta et al., 1998
). Accordingly, IL-1 is suggested to
contribute to ulcer healing through COX-2 induction and the elevation
of PG production.
Second, we found that IL-1 stimulates the induction of iNOS mRNA
expression in gastric ulcers. It is well known that IL-1 causes iNOS
mRNA expression in several cell types (Förstermann et al., 1995
).
In addition, we found that the total NOS activity is markedly elevated
in the ulcerated tissue and is due predominantly to iNOS activity. It
is generally accepted that at inflammatory sites, NO production is
highly increased by iNOS (Förstermann et al., 1995
; Dinarello,
1996
). These results suggest that iNOS expressed in gastric ulcers
provides a considerable amount of NO. Konturek et al. (1993)
reported
that NO plays an important role in gastric ulcer healing. Taken
together, it is suggested that IL-1 enhances NO production as well as
PG production, thereby contributing to gastric ulcer healing.
Third, we found that CINC-1 mRNA expression is also induced by IL-1 in
gastric ulcers. IL-1 is also a potent inducer of CINC expression
(Watanabe and Nakagawa, 1987
; Dinarello, 1996
). CINC belongs to the
IL-8 chemokine family, exhibits potent chemotactic activity in vitro
(Shibata et al., 1995
), and acts as a functional chemoattractant for
neutrophils in vivo (Watanabe et al., 1991
; Utsunomiya et al., 1996
).
To date, a rat counterpart of human IL-8 has not been identified, and
CINC is considered to play a crucial role in the acute neutrophil
infiltration in rats (Watanabe et al., 1993
). In the present study,
neutrophil chemotactic activity in the ulcerated tissue significantly
decreased with the reduction in CINC-1 mRNA expression. Exposure of
neutrophils to IL-1
failed to induce chemotaxis. We reported that
neutrophil infiltration occurs into ulcerated gastric tissue and that
both neutrophil chemotactic activity and CINC levels in the ulcerated
tissue decrease with ulcer healing (Fujita et al., 1998
; Yamada et al.,
1999
). These results suggest that CINC-1 is involved in neutrophil
infiltration into the ulcerated tissue and that IL-1 causes neutrophil
infiltration, partly via CINC-1 induction. Our hypothesis is supported
by the finding of Utsunomiya et al. (1996)
that locally injected
IL-1
induces neutrophil chemotaxis indirectly through CINC
production in rats. Because the activation and infiltration of
neutrophils are essential for the elimination of wounded cells, cell
debris, and extracellular matrix proteins before tissue regeneration, the induction of CINC expression by IL-1 is thought to be important for
ulcer healing.
Fourth, our results indicate that IL-1 might up-regulate HGF mRNA
expression in gastric ulcers. This is supported by the finding that HGF
production is promoted by IL-1 in cultured fibroblasts (Tamura et al.,
1993
). As described previously (Kinoshita et al., 1995
), HGF stimulates
the growth of rat gastric epithelial cells, thereby probably
contributing to mucosal regeneration. In contrast, IL-1
had no
effect on epithelial cell growth. In addition, Schmassmann et al.
(1997)
reported that exogenous HGF fails to accelerate gastric ulcer
healing but significantly enhances epithelial cell growth in rats. In
the present study, we showed that growth-promoting activity toward
epithelial cells is reduced with the decrease in HGF mRNA expression
caused by inhibition of the IL-1 action. These results suggest that
IL-1-induced HGF is involved in epithelial regeneration, but it remains
unclear whether endogenous HGF by itself plays a major role in ulcer healing.
Fifth, IL-1 might slightly induce bFGF expression in gastric ulcers.
bFGF had no effect on epithelial cell growth but is well known to
stimulate gastric fibroblast proliferation (Watanabe et al., 1995
) and
to promote angiogenesis (Folkman et al., 1991
; Schmassmann et al.,
1995
; Satoh et al., 1997
). These results suggest that IL-1 participates
in the formation of granulation tissue and angiogenesis in the ulcer
base via bFGF induction.
Furthermore, it is also suggested that the increased expression of EGF
and TGF-
1 mRNAs is not regulated by IL-1 in gastric ulcers. The
mechanism by which EGF and TGF-
1 expression is promoted is unknown
at present.
Finally, administered IL-1RA significantly impaired the healing of acetic acid-induced ulcers in rats, indicating that endogenous IL-1 plays a crucial role in gastric ulcer healing. Taken together the above results, IL-1 might up-regulate the expression of several healing-related factors, contributing to gastric ulcer healing.
Watanabe et al. (1997)
reported that exogenous IL-1
at 1 µg/kg
causes recurrence of acetic acid-induced gastric ulcers in rats. In an
acetic acid-induced ulcer model, ulcers are spontaneously relapsed
after the initial ulcers healed (Takagi et al., 1969
). However, they
did not determine the IL-1
production or examine the role of
endogenous IL-1
in spontaneous recurrence of gastric ulcers. Because
IL-1
was injected intraperitoneally in their study, the systemic
effect of exogenous IL-1
considerably appeared. Accordingly, it is
quite possible that the injurious effect of exogenous IL-1
may be
not physiological but artificial. In contrast, the action of locally
produced IL-1
was examined in this study. Alternatively, IL-1
may
exert opposite effects between ulcer healing and ulcer relapse; IL-1
in active ulcers may induce multiple responses for healing in
granulation tissue, whereas IL-1
in healed ulcers may exert a
deleterious effect toward the regenerated mucosa.
Overall, we conclude that IL-1, expressed in macrophages/monocytes and fibroblasts in the ulcer base, might up-regulate the mRNA expression of COX-2, iNOS, CINC-1, HGF, and bFGF, thereby contributing to gastric ulcer healing in rats.
| |
Acknowledgments |
|---|
We thank N. J. Halewood for critical reading of the manuscript and H. Fujita, E. Nakamura, M. Ishikawa, and S. Kitazawa for technical assistance. In addition, we are grateful to Dr. S. Takahashi (Department of Preventive Medicine, Kyoto Prefectural University of Medicine, Kyoto, Japan) for supporting Northern blot analysis.
| |
Footnotes |
|---|
Accepted for publication July 16, 1999.
Received for publication December 15, 1998.
Send reprint requests to: Satoru Takahashi, Ph.D., Department of Applied Pharmacology, Kyoto Pharmaceutical University, Misasagi, Yamashina, Kyoto 607-8414, Japan. E-mail: takahasi{at}mb.kyoto-phu.ac.jp
| |
Abbreviations |
|---|
IL, interleukin;
bp, base pair;
COX, cyclooxygenase;
iNOS, inducible nitric oxide synthase;
DMEM, Dulbecco's modified Eagle's medium;
CINC, cytokine-induced neutrophil
chemoattractant;
HGF, hepatocyte growth factor;
EGF, epidermal growth
factor;
bFGF, basic fibroblast growth factor;
GAPDH, glyceraldehyde-3-phosphate dehydrogenase;
TGF-
1, transforming growth
factor-
1;
IL-1RA, interleukin-1 receptor antagonist;
PG, prostaglandin.
| |
References |
|---|
|
|
|---|
messenger ribonucleic acid in the rat anterior pituitary and hypothalamus induced by stress.
Endocrinology
136:
873-880[Abstract].
, interleukin-1
, and interleukin-8 production in patients with Helicobacter pylori infection.
Scand J Gastroenterol
29:
425-429[Medline].
, CINC-2
and CINC-3.
Eur J Biochem
231:
306-311[Medline].
and-1
and tumor necrosis factor-
by fibroblasts in culture.
J Biol Chem
268:
8140-8145
1 during gastric ulcer healing in rats.
Dig Dis Sci
42:
616-625[Medline].
.
Am J Pathol
150:
971-979[Abstract].This article has been cited by other articles:
![]() |
M. H. Pillinger, N. Marjanovic, S.-Y. Kim, J. U. Scher, P. Izmirly, S. Tolani, V. Dinsell, Y.-C. Lee, M. J. Blaser, and S. B. Abramson Matrix Metalloproteinase Secretion by Gastric Epithelial Cells Is Regulated by E Prostaglandins and MAPKs J. Biol. Chem., March 18, 2005; 280(11): 9973 - 9979. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. E. Shifflett, F. G. Bottone Jr., K. M. Young, A. J. Moeser, S. L. Jones, and A. T. Blikslager Neutrophils augment recovery of porcine ischemia-injured ileal mucosa by an IL-1{beta}- and COX-2-dependent mechanism Am J Physiol Gastrointest Liver Physiol, July 1, 2004; 287(1): G50 - G57. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Handa, Y. Naito, T. Takagi, M. Shimozawa, S. Kokura, N. Yoshida, H. Matsui, G. Cepinskas, P. R. Kvietys, and T. Yoshikawa Tumor Necrosis Factor-{alpha}-Induced Cytokine-Induced Neutrophil Chemoattractant-1 (CINC-1) Production by Rat Gastric Epithelial Cells: Role of Reactive Oxygen Species and Nuclear Factor-{kappa}B J. Pharmacol. Exp. Ther., May 1, 2004; 309(2): 670 - 676. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Takahashi, T. Fujita, and A. Yamamoto Role of nuclear factor-{kappa}B in gastric ulcer healing in rats Am J Physiol Gastrointest Liver Physiol, June 1, 2001; 280(6): G1296 - G1304. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||